|Articles|August 1, 2003
TNF Inhibitors: Potential for Use in Dermatology Practice
Author(s)Alice B. Gottlieb, MD, PhD
Psoriasis is a chronic inflammatory disease characterized by well-demarcated red, raised, scaly lesions on any part of the body. The disease often severely impacts patients' mental and physical functioning and quality of life. Signs and symptoms may vary from mild to generalized cutaneous involvement, with or without associated joint disease.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Global Hidradenitis Suppurativa Atlas (GHiSA) Finds HS Affects 1% of the World's Population
2
Medicus Pharma Completes Phase 2 Enrollment of D-MNA Study to Non-Invasively Treat BCC
3
Phase 2 Nemolizumab Trial Opens for CPUO
4
First-in-Class Topical GT20029 Demonstrates Promising Phase 2 Efficacy and Tolerability for AGA
5














